Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cysteine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.55 |
| ▸ | ENPEP | Q07075 | 11/20 | 0.37 |
| ▸ | ANPEP | P15144 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL1067775 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5148993 | 0.94 | — | — | |
| Cysteine SCHEMBL3749540 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL4872171 | 0.94 | — | — | |
| Cysteine SCHEMBL9335155 | 0.94 | — | — | |
| Cysteine SCHEMBL23903319 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5410178 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5410181 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5046066 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL6570272 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090123987-A1 | Extracting and purifying limit dextrinases | BAKEX AG (CH) | 2009-05-14 | — | — | US | disclosed |
| WO-2007022597-A1 | EXTRACTING AND PURIFYING LIMIT DEXTRINASES | PROTECH RESEARCH PTY LTD (AU) | 2007-03-01 | — | — | WO | disclosed |
| US-6531608-B2 | Complexes of L-cysteine, N-acetyl L-cysteine, N-(2-mercaptopropionyl)glycine, L-2-oxothiazolidine-4-carboxylate with a metal (copper, magensium or selenium), used for treating chronic glaucoma, | CHRONORX, LLC. | 2003-03-11 | — | — | US | disclosed |
| US-20020151533-A1 | Clinical applications for various thiol complexes and processes for their synthesis | CHRONORX, LLC. | 2002-10-17 | — | — | US | disclosed |
| US-6429219-B1 | ADMINISTERING TO TREAT GLAUCOMA, DIABETES, MACULAR DEGENERATION, NEURODEGENERATIVE DISEASES AND VASOCONSTRICTION | CHRONORX, LLC | 2002-08-06 | — | — | US | disclosed |